Early detection of cardiovascular-renal-metabolic conditions: from silent to seen
Boehringer Ingelheim
Boehringer Ingelheim
Ministry of Health of Malaysia, Devex, AstraZeneca
Foreign Policy, the Egyptian Ministry of Health, the Chinese National Health Commission
World Diabetes Foundation, Resolve to Save Lives, Helmsley Charitable Trust
NCD Alliance
Ministry of Health of Spain, Menoglobal, Global Health Strategies
Economist Impact, sponsored by Eli Lilly
Business Council for International Understanding, Children’s HeartLink, the Ministry of Health and Social Services of the Republic of Namibia, and Siemens Healthineers
Swedish Institute for Health Economics (IHE), Lung Cancer Policy Network, MSD
Boehringer Ingelheim